Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04755283
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-10
First Post:
2021-02-11
Brief Title:
Safety and Tolerability of Abelacimab MAA868 vs Rivaroxaban in Patients With Atrial Fibrillation
Sponsor:
Organization:
Anthos Therapeutics Inc